Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 181 - 190 of 354 results
-
The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infection
Date:
01/24/2023Locations:
Topics:
Lead Investigators:
-
Olorofim for Invasive Fungal Infections PhIII
Date:
01/03/2023Topics:
Lead Investigators:
-
TB CDC Elimination CY23
Date:
01/01/2023Locations:
Topics:
Lead Investigators:
-
AZD5156/AZD3152 mAbs for Covid-19 Prophylaxis in Immunocompromised Patients
Date:
01/01/2023Locations:
Lead Investigators:
-
Origins and Dynamics of Large Clonotypic HIV Reservoir Cells
Date:
01/01/2023Topics:
Lead Investigators:
-
A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNa in Subjects with Chronic Hepatitis B Virus Infection
Date:
12/02/2022Topics:
Lead Investigators:
-
Tumorigenic role of Clostridioides difficile in early colonic lesions
Date:
12/01/2022Topics:
Lead Investigators:
-
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in HBeAg-negative Nucleos(t)ide Analogue-treated Participants with Chronic Hepatit
Date:
12/01/2022Topics:
Lead Investigators:
-
Characterizing CaeA-mediated rifampin tolerance in MTB
Date:
11/10/2022Topics:
Lead Investigators:
-
Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
Date:
10/03/2022Topics:
Lead Investigators: